Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02538094 · ClinicalTrials.gov registry record · NA
tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02538094: Completed NA study, sponsored by Johns Hopkins University.
NCT02538094 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02538094, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This research is being done to determine whether transcranial direct current stimulation (tDCS) can improve certain mental abilities in individuals with multiple sclerosis (MS) or encephalitis. Participants will be asked to come in daily for two full weeks during which time participants will undergo cognitive testing and Magnetic Resonance Imaging (MRI) brain scans. In this research, a very weak electrical current is administered to the surface of the scalp while participants complete cognitive tasks. The investigators' aim is to find out whether tDCS will improve task performance in adults with multiple sclerosis or encephalitis.
Primary Outcome
Change in performance on an individual cognitive test measure raw score from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) battery tests (i.e. Paced Auditory Serial Addition Test scores). Change scores range from -120 to + 120. Positive change scores reflect improvement at the end of the intervention relative to baseline. Negative change scores reflect decline at the end of the intervention relative to baseline.
Interventions
- DEVICE Sham Transcranial direct current stimulation
- DEVICE Anodal Transcranial direct current stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-09 |
| Est. Completion | 2019-06-30 |
| Phase | NA |
What the finished NCT02538094 record still lists
NCT02538094 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham Transcranial direct current stimulation is the first listed.
NCT02538094 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02538094 about?
NCT02538094 is a clinical study titled "tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis". This research is being done to determine whether transcranial direct current stimulation (tDCS) can improve certain mental abilities in individuals with multiple sclerosis (MS) or encephalitis. Participants will be asked to come in daily for two full weeks during which time participants will undergo...
What is the current status of trial NCT02538094?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2014-09. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT02538094?
The interventions under investigation include: Sham Transcranial direct current stimulation (DEVICE), Anodal Transcranial direct current stimulation (DEVICE).
Who is sponsoring clinical trial NCT02538094?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02538094's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia